Latest news
Team-based care model cuts blood pressure in high-risk populations; FDA to convene expert panel on wider access to peptides; Florida nursing assistant sentenced in $11.4M Medicare brace fraud scheme – Morning Medical Update - Medical EconomicsMedical Economics · Sat, 08 Aug 2026 04:09:25 GMTFDA approves Replimune melanoma drug previously rejected twice - STATSTAT · Thu, 06 Aug 2026 20:04:45 GMTStockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Mon, 03 Aug 2026 00:49:26 GMTOn Peptides, FDA Staff Scientists At Odds With Advisory Panel - forbes.comforbes.com · Sun, 02 Aug 2026 12:49:28 GMTFDA Panel Backs 6 Peptides for Compounding - The American Journal of Managed CareThe American Journal of Managed Care · Fri, 31 Jul 2026 07:00:00 GMTUpdated: Replimune scores win as FDA advisors back melanoma treatment, bucking staff concerns - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMTThe (Pep)Tides Turn: FDA Panel Recommends Six of Seven for Compounding - ArentFox SchiffArentFox Schiff · Fri, 31 Jul 2026 05:00:00 GMTCapricor plummets after FDA panel votes against Duchenne heart disease therapy - ReutersReuters · Thu, 30 Jul 2026 07:00:00 GMT